BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Yang C, Chen J, Yu Z, Luo J, Li X, Zhou B, Jiang N. Mining of RNA Methylation-Related Genes and Elucidation of Their Molecular Biology in Gallbladder Carcinoma. Front Oncol 2021;11:621806. [PMID: 33718182 DOI: 10.3389/fonc.2021.621806] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
Number Citing Articles
1 Tong X, Yang X, Tong X, Zhai D, Liu Y. Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance. Front Genet 2022;13:903421. [DOI: 10.3389/fgene.2022.903421] [Reference Citation Analysis]
2 Abdelal H, Chatterjee D. The Clinical and Pathologic Features of Intracholecystic Papillary-Tubular Neoplasms of the Gallbladder. Surg Pathol Clin 2022;15:565-77. [PMID: 36049837 DOI: 10.1016/j.path.2022.05.011] [Reference Citation Analysis]
3 Wan Z, Li X, Luo X, Wang B, Zhou X, Chen A. The miR-590-3p/CFHR3/STAT3 signaling pathway promotes cell proliferation and metastasis in hepatocellular carcinoma. Aging. [DOI: 10.18632/aging.204178] [Reference Citation Analysis]
4 Zeng Z, Lei S, Wang J, Yang Y, Lan J, Tian Q, Chen T, Hao X. A novel hypoxia-driven gene signature that can predict the prognosis of hepatocellular carcinoma. Bioengineered 2022;13:12193-210. [PMID: 35549979 DOI: 10.1080/21655979.2022.2073943] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
5 Manne A, Woods E, Tsung A, Mittra A. Biliary Tract Cancers: Treatment Updates and Future Directions in the Era of Precision Medicine and Immuno-Oncology. Front Oncol 2021;11:768009. [PMID: 34868996 DOI: 10.3389/fonc.2021.768009] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]